JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2023, 72(5):214-222 | DOI: 10.5817/CSF2023-5-214

Preparation and evaluation of spray-dried inhalable microparticles from carrier mixtures

Andrea Peštálová*, Karolína Molatová, Jan Gajdziok
Masarykova univerzita, Farmaceutická fakulta, Ústav farmaceutické technologie, Brno

The formulation of microparticles composed of a mixture of carriers represents an innovative approach for lung drug delivery of dry powder. The carriers used can significantly influence the properties of the microparticles, such as size, shape, surface area, hygroscopicity, or aggregation, thus improving the aerosolization of the drugs after inhalation. The properties mentioned above are crucial for effective pulmonary therapy. The combination of carriers of a carbohydrate nature and gelling agents is advantageous for controlled drug release. The experimental work aimed to prepare by spray drying and subsequently evaluate ten batches of microparticles composed of sugar-based carriers (mannitol, maltodextrin, dextran) and gelling polymers (chitosan, chondroitin sulfate) and to select a suitable combination for follow-up experimental work aimed at drug incorporation into the microparticle matrix. The most suitable parameters were exhibited by batches whose aerodynamic diameter was close to 5 µm, particles prepared from a combination of mannitol and dextran, chitosan and chondroitin, or maltodextrin and chondroitin. These batches also showed the highest fine particle fraction value (> 43%). From a processability point of view, the batch with maltodextrin and chondroitin is preferable due to the lower viscosity of the dispersion and the more regular shape of the final microparticles.

Keywords: microparticles; Mixtures; inhalation administration; carriers; spray drying
Grants and funding:

Práce vznikla za podpory projektu SVVMUNI/A/1140/2021.

Received: April 4, 2023; Accepted: June 29, 2023; Published: May 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Peštálová A, Molatová K, Gajdziok J. Preparation and evaluation of spray-dried inhalable microparticles from carrier mixtures. Čes. slov. farm. 2023;72(5):214-222. doi: 10.5817/CSF2023-5-214.
Download citation

References

  1. Amidi M., Pellikaan H. C., de Boer A. H., Crommelin D. J., Hennink W. E., Jiskoot W. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur. J. Pharm. Biopharm. 2008; 68, 191-200. Go to original source... Go to PubMed...
  2. McArthur A. J., Oliver V. L., Lambert P., French E., Harker J., McIntosh M. P. A Design of Experiments approach to optimising spray drying yield and production efficiency of a model inhaled powder for global health applications. J. Aerosol. Med. Pulm. D. 2022; 35, A13-A14.
  3. Kašáková E., Kašák V. Inhalační systémy na českém trhu pro léčbu pacientů s chronickou obstrukcí průdušek. Praktické lékárenství 2015; 11, 16-18.
  4. Labiris N. R., Dolovich M. B. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Brit. J. Clin. Pharmaco. 2003; 56, 588-599. Go to original source... Go to PubMed...
  5. El-Sherbiny I. M., El-Baz N. M., Yacoub M. H. Inhaled nano-and microparticles for drug delivery. Glob. Cardiol. Sci. Pract. 2015; 1, 2. Go to original source... Go to PubMed...
  6. Jain H., Bairagi A., Srivastava S., Singh S. B., Mehra N. K. Recent advances in the development of microparticles for pulmonary administration. Drug Discov. Today 2020; 25, 1865-1872. Go to original source... Go to PubMed...
  7. Gharse S., Fiegel J. Large porous hollow particles: lightweight champions of pulmonary drug delivery. Curr. Pharm. Design 2016; 22, 2463-2469. Go to original source... Go to PubMed...
  8. Yang Y., Bajaj N., Xu P., Ohn K., Tsifansky M. D., Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 2009; 30, 1947-1953. Go to original source... Go to PubMed...
  9. Newman S. P. Drug delivery to the lungs: challenges and opportunities. Ther. Deliv. 2017; 8, 647-661. Go to original source... Go to PubMed...
  10. Bajerová M., Dvořáčková K., Gajdziok J., Masteiková R., Rabišková M. Metody přípravy mikročástic ve farmaceutické technologii. Čes. slov. Farm. 2009; 58, 6.
  11. Alhajj N., O'Reilly N. J., Cathcart H. Designing enhanced spray dried particles for inhalation: A review of the impact of excipients and processing parameters on particle properties. Powder Technol. 2021; 384, 313-331. Go to original source...
  12. Ferdynand M. S., Nokhodchi A. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler. Drug Deliv. Transl. Re. 2020; 10, 1418-1427. Go to original source... Go to PubMed...
  13. Zhao Z., Wang G., Huang Z., Huang Y., Chen H., Pan X., Zhang X. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance. AAPS PharmSciTech. 2022; 23, 1-11. Go to original source... Go to PubMed...
  14. Huang Y., Huang Z., Zhang X., Zhao Z., Zhang X., Wang K., Wu C. Chitosan-based binary dry powder inhaler carrier with nanometer roughness for improving in vitro and in vivo aerosolization performance. Drug Deliv. Transl. Re. 2018; 8, 1274-1288. Go to original source... Go to PubMed...
  15. Zhao Z., Zhang X., Cui Y., Huang Y., Huang Z., Wang G., Wu C. Hydroxypropyl-β-cyclodextrin as anti-hygroscopicity agent inamorphous lactose carriers for dry powder inhalers. Powder Technol. 2019; 358, 29-38. Go to original source...
  16. Pilcer G., Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int. J. Pharm. 2010; 392, 1-19. Go to original source... Go to PubMed...
  17. Aquino R. P., Auriemma G., Conte G. M., Esposito T., Sommella E., Campiglia P., Sansone F. Development of chitosan/mannitol microparticles as delivery system for the oral administration of a spirulina bioactive peptide extract. Molecules 2020; 25, 20-86. Go to original source... Go to PubMed...
  18. Dabbagh A., Abu Kasim N. H., Yeong C. H., Wong T. W., Abdul Rahman N. Critical parameters for particle-based pulmonary delivery of chemotherapeutics. J. Aerosol Med. Pulm. D. 2018; 31, 139-154. Go to original source... Go to PubMed...
  19. Sosnik A., das Neves J., Sarmento B. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review. Prog. Polym. Sci. 2014; 39, 2030-2075. Go to original source...
  20. Sansone F., Mencherini T., Picerno P., d'Amore M., Aquino R. P., Lauro M. R. Maltodextrin/pectin microparticles by spray drying as carrier for nutraceutical extracts. J.Food Eng. 2011; 105, 468-476. Go to original source...
  21. Inkson B. J. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) for materials characterization. Materials Characterization Using Nondestructive Evaluation (NDE) Methods. 1st ed. United Kingdom: Woodhead Publishing 2016; 17-43. Go to original source...
  22. Holzman M. Laserově indukovaná funkcionalizace porézních titanových povrchů pro biomedicíncké aplikace. https://dspace5.zcu.cz/handle/11025/48859 (11. 12.2022).
  23. Český lékopis. Praha: Grada Publishing 2017. 4912 s.
  24. Chalabala M. Technologie léků. 2. vydání. Praha: Galén 2001; 238-250.
  25. Nayak S., Ghugare P., Vaidhun B. Evaluation of aerodynamic particle size distribution of drugs used in inhalation therapy: A concise review. Int. J. Res. 2020; 7, 264-271. Go to original source...
  26. Ko J. A., Park H. J., Hwang S. J., Park J. B., Lee J. S. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int. J. Pharm. 2002; 249, 165-174. Go to original source... Go to PubMed...
  27. Chen B. T., Cheng Y. S., Yeh H. C. Performance of a TSI aerodynamic particle sizer. Aerosol Sci. Tech. 1985; 4, 89-97. Go to original source...
  28. Jedelský J. Dispergátor pevných částic TSI - SSPD 3433. Dostupné na: http://www.energetickeforum.cz/fsi-vut-v-brne/pristrojove-vybaveni/dispergator-pevnych-castic (28. 7. 2022).
  29. Torres M. A., Beppu M. M., Santana C. C. Characterization of chemically modified chitosan microspheres as adsorbents using standard proteins (bovine serum albumin and lysozyme). Braz. J. Chem. Eng. 2007; 24, 325-336. Go to original source...
  30. Xu D., Xu Y., Liu G., Hou Z., Yuan Y., Wang S., Sun B. Effect of carrier agents on the physical properties and morphology of spray-dried Monascus pigment powder. Lwt. 2018; 98, 299-305. Go to original source...
  31. Wang X., Wan W., Lu J., Quan G., Pan X., & Liu P. Effects of L-leucine on the properties of spray-dried swellable microparticles with wrinkled surfaces for inhalation therapy of pulmonary fibrosis. Int. J.Pharm. 2021; 610, 121-223. Go to original source... Go to PubMed...
  32. Ma Z., Merkus H. G., de Smet J. G., Heffels C., Scarlett B. New developments in particle characterization by laser diffraction: size and shape. Powder Technol. 2000; 111, 66-78. Go to original source...
  33. Perkušić M., Nodilo L. N., Ugrina I., Špoljarić D., Brala C. J., Pepić I., Hafner A. Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery. Int. J. Pharm. 2022; 624, 122038. Go to original source... Go to PubMed...
  34. Manser M., Morgan B. A., Feng X., Rhem R. G., Dolovich M. B., Xing Z., Thompson M. R. Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery. Pharm. Res. 2022; 39, 2315-2328. Go to original source... Go to PubMed...
  35. Rohani S. S. R., Abnous K., Tafaghodi M. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients. Int. J. Pharm. 2014; 465, 464-478. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.